Breast cancer trial with erythropoietin terminated unexpectedly
- PMID: 12901958
- DOI: 10.1016/s1470-2045(03)01163-x
Breast cancer trial with erythropoietin terminated unexpectedly
Comment in
-
Amgen's point of view on epoetins.Lancet Oncol. 2004 Apr;5(4):206-7. doi: 10.1016/S1470-2045(04)01422-6. Lancet Oncol. 2004. PMID: 15050950 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
